Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Black Diamond Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Zevra Therapeutics Inc. May 29, 202574.0%
-
Black Diamond Therapeutics Inc. May 16, 202372.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 15, 2024 | Black Diamond Therapeutics Inc. | Grant or award | +3,253 | $4.54 | $14,769 |
| Dec 15, 2023 | Black Diamond Therapeutics Inc. | Grant or award | +4,043 | $2.73 | $11,037 |
| Sep 15, 2023 | Black Diamond Therapeutics Inc. | Grant or award | +2,986 | $3.60 | $10,750 |
| Jun 16, 2023 | Black Diamond Therapeutics Inc. | Grant or award | +5,119 | $2.10 | $10,750 |
| Jun 15, 2023 | Arvinas Inc. | Grant or award | +4,121 | — | — |
| Mar 16, 2023 | Black Diamond Therapeutics Inc. | Grant or award | +6,437 | $1.67 | $10,750 |
Questions about Wendy L. Dixon
What boards is Wendy L. Dixon on?
Wendy L. Dixon sits on the boards of Arvinas Inc., Black Diamond Therapeutics Inc. and Zevra Therapeutics Inc.
How long has Wendy L. Dixon served on boards?
Our records show at least 11 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.